grant

Identification of Covalent Transcriptional Dependencies in Melanoma

Organization MASSACHUSETTS GENERAL HOSPITALLocation BOSTON, UNITED STATESPosted 14 Jun 2024Deadline 31 May 2029
NIHUS FederalResearch GrantFY2025AddressAffinityAnti-Cancer AgentsAntineoplastic AgentsAntineoplastic DrugsAntineoplasticsApplications GrantsBasal Transcription FactorBasal transcription factor genesBindingBinding SitesBiochemicalBiologic ModelsBiologicalBiological ModelsBiotinCancer DrugCancer GenesCancer ModelCancer TreatmentCancer-Promoting GeneCancerModelCancersCell BodyCell LineCellLineCellsChIP SequencingChIP-seqChIPseqCharacteristicsChemicalsCombining SiteComplexCysteineDNA BindingDNA Binding InteractionDNA boundDNA mutationDependenceDerivationDerivation procedureDevelopmentDrug TargetingDrug TherapyDrugsElementsEnzyme GeneEnzymesFoundationsFutureGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGeneralized GrowthGenesGeneticGenetic ChangeGenetic TranscriptionGenetic defectGenetic mutationGenomicsGluesGoalsGrant ProposalsGrowthHalf-CystineHuman GeneticsImmuneImmunesKinasesL-CysteineLabelLearningLibrariesLigand BindingLigandsMalignant MelanomaMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant Skin NeoplasmMalignant TumorMedicationMedicinal ChemistryMedicineMelanomaMelanoma CellMetabolicMethodsModel SystemMolecularMolecular InteractionMonitorMutateMutationNeoplastic Disease Chemotherapeutic AgentsOncogenesOncogenesisOncogenicOutcomePatientsPharmaceutic ChemistryPharmaceutical ChemistryPharmaceutical PreparationsPharmacological TreatmentPharmacotherapyPhosphotransferase GenePhosphotransferasesProliferatingProteinsProteomeProteomicsRNA ExpressionRNA SeqRNA sequencingRNAseqReactive SiteRegulationReporterResearchRoleShapesSiteSkin CancerStrains Cell LinesSynthesis ChemistrySynthetic ChemistryTechnologyTestingTissue GrowthTranscriptionTranscription Factor OncogeneTranscription Factor Proto-OncogeneTranscription factor genesTransforming GenesTransphosphorylasesTumor-Specific Treatment AgentsValidationVitamin Hanaloganti-cancer druganti-cancer researchanti-cancer therapybiologicbiophysical approachesbiophysical methodologybiophysical methodsbiophysical techniquescancer researchcancer sub-typescancer subtypescancer therapycancer-directed therapychromatin immunoprecipitation coupled with sequencingchromatin immunoprecipitation followed by sequencingchromatin immunoprecipitation with sequencingchromatin immunoprecipitation-seqchromatin immunoprecipitation-sequencingcoenzyme Rcultured cell linedevelopmentaldrug discoverydrug interventiondrug treatmentdrug/agentfunctional genomicsgenome mutationimprovedinhibitormalignancymalignant skin tumormelanoma cancer modelmelanoma modelmelanoma tumor modelneoplasm/cancernext generationnovelontogenypharmaceutical interventionpharmacologicpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticspre-clinical developmentpreclinical developmentprogramsprotein protein interactionsmall molecular inhibitorsmall moleculesmall molecule inhibitorsocial rolespheroidssuccesstargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttooltranscription factortranscriptome sequencingtranscriptomic sequencingtumortumorigenesisvalidations
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY/ABSTRACT
Advances in human genetics have identified 400+ genes that when amplified or mutated promote

tumorigenesis. While there has been substantial success in developing drugs for kinases and metabolic

enzymes deregulated in cancer, they represent only a tiny fraction of the cancer drivers discovered to date.

The vast majority…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →